Inactive X chromosome-specific histone H3 modifications and CpG hypomethylation flank a chromatin boundary between an X-inactivated and an escape gene by Goto, Yuji & Kimura, Hiroshi
Inactive X chromosome-specific histone H3
modifications and CpG hypomethylation flank
a chromatin boundary between an X-inactivated
and an escape gene
Yuji Goto
1,2 and Hiroshi Kimura
1,3,*
1Nuclear Function and Dynamics Unit, Horizontal Medical Research Organization, Graduate School of
Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8501,
2College of Life and Health Sciences, Chubu University,
Kasugai, Aichi 487-8501 and
3Graduate School of Frontier Biosciences, Osaka University, 1-3 Yamadaoka,
Suita, Osaka 565-0871, Japan
Received August 6, 2009; Revised September 24, 2009; Accepted September 26, 2009
ABSTRACT
In mammals, the dosage compensation of sex
chromosomes between males and females is
achieved by transcriptional inactivation of one of
the two X chromosomes in females. However,
a number of genes escape X-inactivation in
humans. It remains poorly understood how the
transcriptional activity of these ‘escape genes’ is
maintained despite the chromosome-wide hetero-
chromatin formation. To address this question, we
analyzed a putative chromatin boundary between
the inactivated RBM10 and an escape gene, UBA1/
UBE1. Chromatin immunoprecipitation revealed that
trimethylated histone H3 lysine 9 and H4 lysine 20
were enriched in the last exon through the proximal
downstream region of RBM10, but were remarkably
diminished at  2kb upstream of the UBA1 tran-
scription start site. Whereas RNA polymerase
II was not loaded onto the intergenic region,
CTCF (CCCTC binding factor) was enriched around
the boundary, where some CpG sites were
hypomethylated specifically on inactive X. These
findings suggest that local DNA hypomethylation
and CTCF binding are involved in the formation
of a chromatin boundary, which protects the
UBA1 escape gene against the chromosome-wide
transcriptional silencing.
INTRODUCTION
The unbalanced gene dosage of sex chromosomes between
males (XY) and females (XX) represents an impediment
to normal development. In mammals, X-chromosome
inactivation (XCI) is achieved by transcriptional silencing
of all but one of the X chromosomes in a diploid female
cell, to equalize the gene dosage of X chromosomes
between males and females (1). The XIST/Xist gene,
which maps to the X-inactivation center, is expressed
from the inactive X-chromosome (Xi) in female somatic
cells (2). XIST/Xist RNA is essential for the initiation of
XCI (3,4), playing a key role as a cis-acting factor in
recruiting the silencing machineries. Once XCI is initiated,
genes on the X chromosome undergo inactivation by
sequential epigenetic modiﬁcations, and an inactive
chromatin status characteristic of heterochromatin is
stably maintained through cell generations. A number of
genes, however, escape XCI in human cells and are
transcriptionally active (5,6); more than 15% of human
X-linked genes are reported to escape the inactivation
(7). These escape genes can be categorized into two
groups based on the presence or absence of Y-homologs.
The distal ends of the short and long arms of the human
sex chromosomes are known as pseudoautosomal regions
1 and 2 (PAR1 and PAR2), which have homologous
sequences with Y chromosome and are required for
X–Y pairing in male meiosis. Most of the genes mapped
on PARs escape XCI (7,8).
A number of genes that do not have Y-homologs, on
the other hand, also escape inactivation in human cells.
However, these genes are mostly inactivated in mice (9).
Such diﬀerent sets of escape genes between human and
mice may reﬂect evolutionary diﬀerences and could
explain the distinct phenotypes when one X is missing.
The absence of a single X-chromosome in humans (45,
X) results in Turner syndrome, which shows a more
severe phenotype compared to X0 mice (10). This
suggests that double dose of transcription found in
escape genes without Y-homolog is crucial for normal
female development in human but not in mice, but the
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Post-translational histone modiﬁcations like acetylation
and methylation play important roles in the epigenetic
control of gene expression in eukaryotes, in addition to
DNA methylation (11–13). Hypoacetylation of histone
H4 and methylation at lysine 9 and 27 of H3 (H3K9
and H3K27), for instance, are associated with chromatin
compaction and gene repression. In contrast, euchromatic
domains display higher levels of histone acetylation
(14–17). Recent studies established that the methylation
of H3K9 and H3K27 is an early event in the XCI
process (18–22) proceeding to DNA methylation on the
promoters of inactivated genes (23). In contrast to the
inactivated genes, the escape genes lack DNA methylation
and H3K9 methylation and are associated with euchro-
matic features like histone acetylation, H3K4 methylation,
and early replication (24,25).
Here we analyse the transcriptional status of escaped
genes and their neighbouring genes to analyze chromatin
boundaries in detail. For this, we used human–mouse
hybrid cells carrying either active or inactive human X
chromosome in mouse background. We then focused on
the RBM10-UBA1/UBE1 locus on Xp11.23, where the
inactivated RBM10 and escape UBA1 are separated by
only four kilobases of intergenic sequences. By proﬁling
histone modiﬁcations using chromatin immunopre-
cipitation (ChIP), we detect a chromatin boundary in
the RBM10-UBA1 intergenic region. Trimethylated
H3K9 and H4K20 (H3K9me3 and H4K20me3) were
enriched in the last exon through the proximal down-
stream region of RBM10 but were strongly diminished
at  2kb upstream of UBA1 on Xi. As previously found
in other boundaries on Xi (26), ChIP also revealed asso-
ciation of CTCF to the intergenic region, suggesting the
involvement of this zinc ﬁnger protein in maintaining the
transcriptional activity of UBA1 and its downstream
escape genes.
MATERIALS AND METHODS
Cells and cytogenetics
A9 (7149)-5 (27) and CF150 (28) cells harboring human
active and Xi chromosomes, respectively, were generous
gifts of Dr M. Oshimura and Dr T.K. Mohandas. All cell
lines were maintained in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 10% fetal bovine
serum in a 5% CO2 incubator.
For cytogenetic analysis, cells were incubated in 100mg/
ml 5-bromo-20-deoxyuridine (BrdU) for 6h, 1mg/ml
colcemid was added to the culture medium, and cells
were further incubated for 1h. Chromosome spreads
and staining were prepared according to the method
described previously (29). Brieﬂy, cells were treated with
75mM KCl for 10min, ﬁxed with 3:1 methanol: glacial
acetic acid on ice, and air-dried on clean glass slides.
Chromosome spreads were stained with freshly prepared
acridine orange (Sigma) and examined under a ﬂuores-
cence microscope (BX-81; Olympus) using an oil-
immersion 100  UPlanApo objective lens (NA: 1.35)
equipped with a cooled CCD (ORCA-ER; Hamamatsu
Photonics).
RNA extraction and RT–PCR
Total RNA was prepared from each cell line using TRIzol
(Invitrogen) and treated with RNase-free DNase I
(Roche). To check the transcriptional status of X-linked
genes, cDNA was synthesized from 1mg RNA using
SuperScript VILO cDNA synthesis kit (Invitrogen) as
described by the manufacturer. To detect the sense/
antisense transcripts in RBM10-UBA1 intergenic region,
cDNA was synthesized from 2mg RNA using One-step
RT–PCR kit (Qiagen) using a strand-speciﬁc primer as
described by the manufacturer. To avoid primer-
independent reverse transcription due to the secondary
structure, the reaction mixture was incubated at 60 C.
Quantitative PCR was performed with Power SYBR
Green PCR Master Mix (Applied Biosystems) using a
7500 FAST (Applied Biosystems). Each PCR was run in
triplicate to control PCR variation. All primers used here
(summarized in Table 1) have proven to be species-
speciﬁc.
Chromatin immunoprecipitation using native chromatin
We used mouse monoclonal antibodies speciﬁc to diﬀerent
H3 modiﬁcations (30) and commercial antibodies
including di+tri-methyl H3K4 (H3K4me2+3; Abcam;
ab6000), di-methyl H3K9 (H3K9me2; Abcam; ab1220),
tri-methyl H3K27 (H3K27me3; Abcam; ab6002), tri-
methyl H4K20 (H4K20me3; Abcam; ab9053). Control
mouse IgG (Jackson Immunoresearch) was also used.
To proﬁle the histone modiﬁcations, native chromatin
was prepared and used for chromatin immunopre-
cipitation (ChIP) assay as described previously (15,31)
with slight modiﬁcations. Brieﬂy,  15mg of native
chromatin ( 2–4 nucleosomes) was incubated with
15–20ml hybridoma culture sup or 10–20mg IgG for 15h
at 4 C in ChIP buﬀer [25mM Tris–HCl (pH 7.6), 500mM
NaCl, 5mM EDTA and Protease inhibitor cocktail
(Roche; Complete, EDTA-free)]. After further incubation
for 2h with 80ml Dynabeads M-280 Sheep anti-mouse
IgG (for mouse IgG; Dynal), or 50ml Dynabeads
Protein G (for rabbit IgG; Dynal), chromatin-antibody
complexes (‘bound’ fraction) were separated from
antibody-free chromatin (‘unbound’ fraction) using a
magnetic stand (Dynal). After rinsing three times with
ChIP buﬀer, bound-chromatin was eluted from the
beads using ChIP buﬀer containing 1% SDS. At least
three independent ChIP experiments were performed for
each antibody.
ChIP using cross-linked chromatin
To analyze the binding of CTCF and RNA polymerase
with the chromatin, we used another ChIP method using
cross-linked chromatin as described before (30,32).
Sonicated chromatin ( 300–1500bp;  15mg) was
incubated with mouse monoclonal anti-CTCF (BD
transduction Laboratories, 612148; 15mg), anti-RNA
polymerase, B8-1 (33) (10mg), 8WG16 (Covance; 10ml)
and H14 (Covance; 10ml), or normal mouse IgG
Nucleic Acids Research, 2009,Vol.37, No. 22 7417(Jackson Immunoresearch; 5mg) for 15h at 4 C in RIPA
buﬀer [50mM Tris–Cl (pH 8.0), 150mM NaCl, 1mM
EDTA, 1% Triton X-100, 0.1% sodium deoxycholate
and Protease inhibitor cocktail (Complete, EDTA-free;
Roche)]. After further incubation for 2h with 80ml
Dynabeads M-280 Sheep anti-mouse IgG (Dynal), or
anti-mouse IgM (Dynal) for H14, immunoprecipitates
were collected, washed with RIPA buﬀer containing
150mM and 500mM NaCl, and resuspended in 200ml
of 10mM Tris–HCl (pH 8.0), 5mM EDTA, 300mM
NaCl and 0.5% SDS. The chromatin-bound beads
(‘bound’ fraction) and the input fraction were incubated
at 65 C for 12h to reverse the cross-linking.
Quantitative analysis of ChIP samples
DNA was extracted from the input, ‘bound’ and
‘unbound’ fractions with phenol/chloroform, precipitated
with ethanol, and re-suspended in 60ml TE [10mM Tris–
HCl (pH 7.6) and 1mM EDTA]. The DNA sample (1ml)
was used for quantitative PCR with QuantiTect SYBR
Green PCR (Qiagen) using an Opticon2 (BioRad). Each
Table 1. PCR primers
Application Gene name Forward (50 to 30) Reverse (50 to 30)
RT–PCR POLA aaaggggcagatgaggaac ttcccaaacagaaataccacac
PGK1 aaagggaagcgggtcgttatc tgcccagcagagatttgagt
XIST gatgggttgccagctatc ggatcctcatgccccatctc
RBM10 ggacctatgttcccgccc ctcgtcatctcgcaggga
UBA1 TSS1 ttccgagctccgcgcaaact gcacttcggacaacacggactg
UBA1 TSS10 ttgtgtcggcggctcggctgtaag gcacttcggacaacacggactg
USP11 catgaaacatccattcttcctcagtc ctgagtcaggcatcgacgaa
ZNF157 aggaccctctacacacagacagc ctgtcgggtgaaatccacagccac
KLHL15 atcattcagaatatccggttttgct ttcaatgcttggtcaacttcgtaa
EIF2S3 ctgtcctggccacgatattt aggtgttccgatgtctgagg
ZFX ctgatcctctgactaccgacgtagtt aatcataaggtagtcctcacagttgcc
Mouse Tbp accacccccttgtacccttc tttacagccaagattcacggtag
ChIP and strand-speciﬁc
RT-PCR
RBM10 Ex20 gaggactggtggcagccta ccagtcggtgagcttctcct
RBM10 Ex22 cagctgaacgcagagaaaag atatgccgccgtacttcctc
RBM10 Ex24 gggcagggaaggacagagtg gatttggtcaagccctctctg
RU1 ctagcaccaccaggcatgaa tccagatctagggatggcaaa
RU2 ccagcaatttaggaggctga tgcgcccagcctaattttat
RU3 ggaacaacccaaatgtccaa caccatgtgaacaatctcacca
RU4 tcaaatgccaaaactgttcca cacatcatctgggccctttt
RU5 accacagatgcaccccacta tgaggcaggatgattgcttg
RU6 ccacctgagtctcggtctcc gcaccagcgtccagaatatg
UBA1 Ex1 ttccgagctccgcgcaaact ttcctgccaaagatgagctgaagc
Intron(In) 1 1 ggaggctcaggactgcgagac ggcgcctcgtcagctcagga
In1 2 gggatgaggcctcctacattgtt cctcatacccattattcaggcttac
In1 3 ctccatcgcaaggtaagttgctg gggatgagccttagaacattgctggc
In1 4 gctgggattacaggcgtcatct ccgcctcaggaacaaggg
In1 5 gcagcaataggcgggcgt gccacacacccccattcat
UBA1 Ex10 ttgtgtcggcggctcggctgtaag ccgccaactcctcaaggagccgaa
In10 1 acatgctagccgcgctcag ggaagatgctagggccaggg
In10 2 tgcagtcaggggttttcagctt cctggacgacatagtgaaacaattctg
In10 3 caccctcagagcagctgtgatacc gaggctgtgagggtggatgg
In10 4 cccagaaagcttgacatgctcc gggtttgagggaggagtcttggag
In10 5 cctcaggtcagtgagttctgaccacag ctgactgacctggggtagagatctc
In10 6 tcagtgtgggaggacttgtgtgaa ctggtggtgggggtgactg
In10 7 cggttttcccctcccaaagc gagtgcaggagggaagtgaggc
UBA1 Ex2 atgtccagctcgccgctgtccaag gcacttcggacaacacggactg
XIST+1 ccttcagttcttaaagcgctgcaa ggtgatttttttaaagaaatacgccat
XIST+780 tgggttgttgcactctctgg ctgcctgacctgctatcatcc
PGK1+98 gcacgtcggcagtcggct cctcataacgacccgcttccc
PGK1+700 acttgctggcctccaatctc agaaaccgtgttggcaagtg
RBM10+67 gtaggcggcagtgagtttcc tcctccaactctcccagctc
RBM10+600 ccacttattgggtgggaagg tttccatggatgagcgtcag
H19 ICR ccgagaaaatagccattgcctacagt catgttcctttgagtcctgggtgta
Eif2 ggttggaggccagtatgaga cggcaacatgctgttaagac
KIAA0522 agccagctgggataaggaat cctggggtcttcacctaaca
Bisulﬁte sequencing RBM10 Ex24 gggtagggaaggatagagtgttg aactccacctccacccctcta
RU2 to RU3 ggttttttgggtttgggtatagtgagttg aaaatttcactcttatcccccaaac
RU5 agtttgttaaagtgatgggattatagg ccaaactaaactaaaactcctaaactcaaac
RU6 to UBA1 Ex1 gggtgtgtttttttatgtggaggt caccctcctccaaatactatc
In1 1 ggtattgtggaggtgttaggtttttgtg caaaacgccccttcaacacgtccc
In1 4 gttgtggaaattgaggtatttgttaaag cacccaaaactaccctacccaac
UBA1 Ex10 gtttttgggggtggggtttaag aaatccactccccctccctactc
7418 Nucleic Acids Research, 2009,Vol.37, No. 22PCR was run in triplicate to control PCR variation.
Primers used here are listed in Table 1.
DNA methylation assay
Bisulﬁte treatment was carried out using EZ DNA
methylation kit (ZYMO RESEARCH) according to
the manufacturer’s instruction, and the completion of
reaction was conﬁrmed using control samples containing
non- and fully-methylated templates. To amplify bisulﬁte-
treated genomic DNA, primers for PCR ampliﬁcation are
designed to contain degenerate nucleotides (C to T) except
CpG dinucleotide sequence (Table 1). PCR products
were cloned into Topo-TA vector (Invitrogen) and
the nucleotide sequence was determined using a
PRISM3100-Avant (ABI).
RESULTS
Status of human X chromosomes in hybrid cell lines
resembles that in diploid human cells
To analyze active and inactive X chromosomes (Xa and
Xi) separately, we used human–mouse hybrid cell lines,
A9 (7149)-5 [hereafter described as HX; (27)] and
CF150 [CF; (28)] harboring active and inactive human
X-chromosome, respectively. These were generated by
microcell-mediated chromosome transfer into mouse
A9 cells.
We ﬁrst examined whether the active or inactive status
of human X chromosomes was maintained in HX and CF
cells. By quantitative RT-PCR, the expression of several
human X-linked genes was examined in A9 (parent mouse
cells; a negative control), HX and CF, and compared with
that in diploid human male and female cells (i.e. MRC5
harboring Xa and WI38 harboring both Xa and
Xi, respectively) (Figure 1A and B). The expression of
typical human X-linked genes that are repressed on Xi
(i.e. POLA, PGK1 and G6PD) was detected in cells har-
boring human Xa, such as HX, MRC5 and WI38 (Figure
1B, top; data not shown). In contrast, XIST was expressed
in cells harboring human Xi (CF and WI38; Figure 1B,
top). To evaluate the replication timing of human X
chromosomes in hybrid cells, the cytogenetic examination
using R-banding (29) was employed. In chromosome
spreads from HX cells, human X exhibited a typical
banding pattern of active X (Xa) due to its asynchronous
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Figure 1. The status of human X chromosomes in the human–mouse hybrid cell lines. (A) Schematic human X-chromosome map with the
inactivated and escape genes examined in this study. (B) Quantitative RT–PCR analysis of human X-linked genes in diﬀerent cell lines. Total
RNA was prepared from A9 (parental mouse cell line for HX and CF: without human X), HX (mouse line harboring active human X), CF (mouse
line harboring inactive human X), MRC5 (46, XY; male diploid human cells harboring active X) and WI38 (46, XX; female diploid human cells
harboring active and inactive Xs). The levels of transcripts were analyzed using real-time PCR, and expressed as relative amounts to human TBP (for
MRC5 and WI38) or mouse Tbp (for A9, HX and CF). (C) Representative X chromosome banding patterns. After the incubation with BrdU for 6h
to label late replicating DNA, cells were treated with colcemid for chromosome spreading and R-banding. A typical human active X chromosome
is observed in HX cell spread (left panel; arrowhead). In CF cell spread, human inactive X chromosome shows homogenous dimmer staining
(right panel; arrow).
Nucleic Acids Research, 2009,Vol.37, No. 22 7419replication, whereas all human X in CF spreads appeared
as homogenous late replication staining, characteristic of
the Xi (Figure 1C). These results indicated that human Xa
and Xi were stably maintained in hybrid cell lines HX and
CF, respectively (27,28).
To explore the chromatin boundary between inactivated
and escape genes, we next validated the expression of
three previously reported escape genes (2,7,34,35), UBA1
(ubiquitin-like modiﬁer activating enzyme 1; also known
as UBE1) and PCTK1 (PCTAIRE protein kinase 1),
EIF2S3 (eukaryotic translation initiation factor 2,
subunit 3 gamma) and their ﬂanking genes (Figure 1A
and B). UBA1 consists of two transcription start sites
(TSSs) with the alternative non-coding ﬁrst exons.
Hereafter, the ﬁrst TSS is numbered +1 and called
UBA1 TSS1, and the second, alternative TSS (at +3036)
called UBA1 TSS10; accordingly, the ﬁrst exons from
TSS1 and TSS10 are called Ex1 and Ex10, respectively.
Quantitative RT-PCR analysis showed that the transcripts
from Ex1 were detected in HX, MRC5 and WI38, and
those from Ex10 in all cells harboring human X including
CF (Figure 1B, middle). The relative amount of UBA1
Ex10 transcripts was roughly 2-fold in WI38 compared
with MRC5, whereas that of Ex1 was comparable in the
two. These results suggest that TSS10, but not TSS1,
escaped inactivation in UBA1 gene in WI38 and CF.
In the same locus, transcripts from 30 ﬂanking genes
to UBA1 (i.e. PCTK1 and USP11) were detected in
all cell lines including CF harboring Xi (Figure 1B,
middle), conﬁrming previous data showing these genes
escape from silencing as a cluster in other cell lines
(7,34). In contrast, the expression of RBM10, located
4kb upstream of UBA1, was detected only in the cells
containing Xa (Figure 1B, middle), like other typical
X-linked genes that undergo X-inactivation.
Another previously known escape gene EIF2S3 was
transcribed from both human Xa and Xi in hybrid cells
(Figure 1B, bottom), as anticipated (7,35). Among the
genes near EIF2S3 (Figure 1A), KLHL15 (Kelch-like 15)
located 28kb upstream EIF2S3 was silenced in Xi
(Figure 1B, bottom). In contrast, zinc ﬁnger protein,
X-linked (ZFX), which is located 72kb downstream
EIF2S3 and known to be an escape gene (7), was
transcribed in all cells (Figure 1C). We did not obtain
any evidence for the expression of LOC347438/
FAM48B1 (family with sequence similarity 48, member
B1), a single exon gene located further 99kb downstream,
in any cell lines tested here (data not shown).
These results are entirely consistent with the previous
data obtained by diﬀerent hybrid cells (7,34), supporting
the notion that clusters of genes spanning tens of kilobases
escape X-inactivation constituting escape domains,
and that chromatin boundaries between inactivated
and escape regions should be present in the intergenic
intervals.
Histone modiﬁcation proﬁle in RBM10-UBA1
intergenic region
As the inactivated RBM10 and escape gene UBA1 are
only  4kb apart, we focused on this region to investigate
the boundary between silenced and active chromatin
using hybrid cells. By using ChIP, we proﬁled histone
modiﬁcations characteristic to euchromatin and hetero-
chromatin along a 14kb region covering the last exon of
RBM10 through the second exon of UBA1 (Figure 2).
Histone H3 K9 acetylation and K4 methylation are in
general regarded as euchromatic modiﬁcations associated
with the transcriptional activation (12,36–38). ChIP of
di+tri-methyl H3K4 (H3K4me2+3) showed that
these modiﬁcations were highly enriched around TSS1
and TSS10 on Xa (HX), and around TSS10 on Xi (CF)
(Figure 2B), in good agreement with their transcription
status (Figure 1B). As H3K4me2 distributed downstream
H3K4me2+3, H3K4me3 appeared to be enriched more
proximal to the TSSs. H3K4me1 was observed further
downstream. H3K9ac was also enriched at active TSSs
and downstream. Thus, all modiﬁcations characteristic
to active chromatin were found at active TSSs and down-
stream but not in the intergenic region between the 30-end
of RBM10 and UBA1 TSS1. These results suggest that the
active markers are simply correlated with transcription
activities and may not be used as particular marks at the
chromatin boundary in this locus.
H3K9me2 and H3K9me3 were reported as key
modiﬁcations for heterochromatin formation and mainte-
nance (12). Whereas H3K9me3 was observed little
throughout the intergenic region of RBM10-UBA1 locus
on Xa, the same modiﬁcation was highly enriched in
inactivated RBM10 last exons through the proximal
downstream region on Xi (Figure 2C). The level of
H3K9me3 was remarkably diminished at the intergenic
region between RBM10 and UBA1 ( 2kb upstream
UBA1 TSS1) and disappeared at active TSS10 on Xi
(Figure 2B). ChIP assay using two independent speciﬁc
antibodies indicated that H3K9me2 showed similar distri-
bution to H3K9me3. H3K9me1 was broadly detected
from RBM10 to UBA1 except at around TSSs
(Figure 2C). The level of monomethylation was relatively
high in RBM10 transcribed region on Xa. As H3K9me1
was also enriched in UBA1 transcribed region on Xa and
Xi, this modiﬁcation seems to be correlated with active
chromatin, in good agreement with recent genome-wide
analysis (38).
We further examined other modiﬁcations associated
with repressed chromatin such as H3K27me3 and
H4K20me3 (21,39). H4K20me3 was highly enriched in
the inactivated RBM10 to intergenic region on Xi simi-
larly to H3K9me3 (Figure 2D). In contrast, enrichment
of H3K27me3 was restricted to the transition point
of H3K9me3 and H4K20me3 on Xi (Figure 2D). From
these results, the heterochromatic feature of H3K9me3
and H4K20me3 enrichment in the intergenic proximal of
RBM10 appears to be disrupted at  2kb upstream of the
UBA1 TSS1, and a chromatin boundary is established at
this region.
Little transcription around the RBM10-UBA1
chromatin boundary
Non-coding transcripts are often found in locus con-
trol regions that regulate transcription of structural
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Nucleic Acids Research, 2009,Vol.37, No. 22 7421genes (40–44) and siRNA could participate in establishing
heterochromatin (45–48). Therefore, we investigated
whether we could detect transcripts from the RBM10-
UBA1 intergenic region using strand-speciﬁc quantitative
RT-PCR (Figure 3A and B).
RBM10 mRNA was clearly detected along the last
several exons by priming RT with the reverse primer
in HX harboring Xa, but not in CF harboring Xi
(Figure 3B). In RBM10 proximal downstream regions
(encompassing to the regions designated RU1 to RU3,
from  3808 to  1595), sense transcripts primed with the
reverse primers were also detected in HX (Figure 3B).
These transcripts were likely to be read-through from
RBM10 transcription unit, as the exon sequences were
ampliﬁed from cDNA primed with the reverse primers
in the intergenic regions (RU1-3) (data not shown).
Antisense transcripts in these RBM10 proximal regions
were, in contrast, undetectable in both cells under the
similar experimental conditions. Transcripts from either
direction were not detected in RU4 region (from  1722
to  1595) in both tested cells (Figure 3B). Subtle antisense
transcripts, primed with the forward primers, were
observed in RU5 (from  1010 to  915) and RU6 (from
 308 to  223) regions through UBA1 gene on both
Xa and Xi. These results suggest that RBM10 read-
through and UBA1 antisense transcripts are terminated
before approaching to RU4 region. We also detected
weak signals of UBA1 sense transcripts in RU6 region in
cells harboring Xa (HX). In UBA1 gene, the sense
transcripts were clearly detected in the ﬁrst exons (Ex1
and Ex10, starting from TSS1 and TSS10, respectively)
and exon 2 (Ex2) in HX, whereas the transcripts were
only detected in Ex10 and Ex2, but not in Ex1, in CF
(Figure 3B), consistent with the ChIP data with
methylated H3K4 and H3K9ac associating with active
TSSs (Figure 2).
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7422 Nucleic Acids Research, 2009,Vol.37, No. 22To reﬁne these results, we also used ChIP assay to inves-
tigate the presence of RNA polymerases in RBM10-UBA1
locus by using three monoclonal antibodies recognizing
diﬀerent forms (Figure 3C). B8 reacts with RPB8, a
shared subunit of RNA polymerases I, II and III (33),
and so chromatin fragments bound by any polymerase
could be precipitated. 8WG16 and H14 recognize
unphosphorylated and Ser5-phosphorylated forms of
the C-terminal domain in the largest subunit of
RNA polymerase II, respectively (49,50). While the
pre-initiation complex on a promoter contains unphos-
phorylated form, Ser5 is phosphorylated during the
initiation of transcription or when polymerases slow
down at the posing and termination sites (51,52). ChIP
with these antibodies revealed that RNA polymerase II
was enriched around active RBM10 TSSs (Figure 3C).
Ser5-phosphorylated form (recognized by H14) was
subtly detected from the last exons of RBM10 to the
proximal intergenic region (RU1 and in particular RU2,
but not RU3), exclusively on Xa, which is probably
associated with the termination of read-through trans-
cripts. As polymerases were not detected in the intergenic
region on Xi (Figure 3C), any speciﬁc transcripts, or tran-
scription as such, does not appear to be crucial for the
formation and maintenance of the chromatin boundary
in this region.
CpG hypomethylation and CTCF binding around
the chromatin boundary on Xi
We next investigated DNA methylation at the RBM10-
UBA1 locus (Figure 4A). CpG dinucleotides on Xa were
almost fully methylated from the last exon of RBM10
through the intergenic regions (RU2 and RU5), and
hypomethylated near TSS1 (RU6) and exon 1 of UBA1.
CpG hypomethylation was also found in the 50 region of
the ﬁrst intron (In1 1) and around TSS10, but CpGs
at the 30 region of the ﬁrst intron (In1 4) were
fully methylated. These results suggest that CpG
hypomethylation is limited around active TSSs including
promoter and enhancer elements on Xa. In contrast, while
most CpG sites were fully methylated on Xi other than
around TSS10, some CpGs in RU2 and In1 1 regions
were remarkably protected from the methylation
(Figure 4A). Such Xi-speciﬁc CpG hypomethylation
might be involved in the chromatin boundary formation.
CTCF is known to be a methylation-sensitive DNA
binding protein with chromatin insulator and enhancer
blocking function (53–55). As CTCF also binds to 50
regions of escape genes like Jarid1c and Eif2s3 (26), we
investigated CTCF binding in RBM10-UBA1 locus. By
homology search with the previously reported CTCF
binding motif CCGCNNGGNGGCAG (56), several
potential CTCF binding sites were found in RU1, RU2,
In1 1 and In1 4, close to the hypomethylated CpG sites
(Figure 4A). We then examined the CTCF binding in
these regions using cross-linked ChIP (Figure 4B).
In both HX and CF cells, the positive-control loci,
including mouse H19 ICR [imprinting control region;
(57)] and human EIF2S3 promoter (26), were enriched
in anti-CTCF immunoprecipitates (data not shown).
CTCF was distributed in the entire RBM10-UBA1
intergenic region on Xi, with peaks at RU2–RU3 and
In1 1–In1 2, in contrast to Xa, where little CTCF
binding is observed (Figure 4B). Thus, the CpG
hypomethylation and CTCF binding around RU2–RU3
region appear to be correlated with the chromatin
boundary formation.
DISCUSSION
A number of genes on human Xi chromosome are
expressed, or escaped from the silencing, even after
the whole chromosome is inactivated in somatic cells. To
distinguish the Xa and Xi alleles, F1 hybrid mice from
diﬀerent parent strains are often used (26); however, the
analysis is restricted to the regions containing small
nucleotide polymorphisms on mouse X chromosome.
Inter-species hybrid cell lines containing only either
active or inactive human X chromosome allow higher res-
olution analysis without allelic examination (7,26). We
here used human–mouse hybrid cells to investigate the
chromatin boundary between inactivated RBM10 and
escape UBA1 genes on human X chromosome. As
summarized in Figure 5, the TSS1 was silenced on Xi,
whereas the TSS1 and the downstream alternative tran-
scription start site (TSS10) were both used on Xa. By
detailed proﬁling of the histone modiﬁcations and tran-
scription status using ChIP and real-time PCR at  500bp
intervals across the intergenic region, a boundary between
inactive and active chromatin was found around the
middle of the intergenic region ( 2kb upstream the
UBA1 TSS1) on Xi. Importantly, similar histone modiﬁ-
cation proﬁles were observed in diploid human ﬁbroblasts.
In male cells harboring only Xa (MRC5), the distributions
of H3K4me1-3 and H3K9me1-3 were similar to those in
HX (Supplementary Figure S1). In female cells harboring
Xa and Xi (WI38), their distributions appeared as
the mixture of HX and CF (Supplementary Figure S1).
These results support the idea that the epigenetic status of
X chromosomes that was established in human cells is
maintained in the hybrid cells, as seen by others (7,26).
We also found CTCF binding and hypomethylated CpG
in this chromatin boundary region speciﬁcally on Xi; in
contrast, H3K9 acetylation and RNA polymerases were
hardly detected (Figure 5).
Histone modiﬁcations around the RBM10-UBA1
boundary on Xi
In the RBM10-UBA1 locus on Xi, H3K9me3 and
H4K20me3 were enriched in RBM10 gene body and the
proximal downstream region but diminished at the middle
in the intergenic region. H3K27me3, a modiﬁcation
enriched in facultative heterochromatin, was distinctively
detected around this boundary region. These data are con-
sistent with the mosaic structure of diﬀerent levels of
heterochromatin found on human Xi (58), and possibly
correlated with the organization of chromatin boundary
formation and maintenance of escape genes.
Nucleic Acids Research, 2009,Vol.37, No. 22 7423In contrast to H3K9me3 and H3K9me2, H3K9me1 was
broadly distributed throughout the transcribed region
other than around active UBA1 TSSs, where H3K9
was heavily acetylated, suggesting that H3K9me1 is
distributed broadly in relatively opened chromatin (38).
All active TSSs also showed the prominent peak of
H3K4me3, associated with those of H3K4me2 and
then H3K4me1 shifted to downstream. These data are
consistent with the previous genome wide and locus
speciﬁc data (36,37,59). The monomethylated form may
be a neutral state for H3K4 in open chromatin, because
unmethylated and higher methylated forms may recruit
DNA methyltransferase 3L (60) and transcription
machineries (61).
Possible mechanisms of chromatin boundary formation
in RBM10-UBA1 locus
CTCF-dependent insulators have been characterized in
-globin and imprinted IGF2/H19 loci (53,54,57,62).
Non-coding transcripts and hyper-acetylation of H3/H4
were often associated with these insulators (63,64),
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7424 Nucleic Acids Research, 2009,Vol.37, No. 22suggesting the involvement of transcription in the insula-
tor function. On mouse and human Xi, CTCF binding has
also been reported at the 50 end of escape genes, Jarid1c,
Eif2s3x and EIF2S3, adjacent to an inactivated gene (26).
Although the boundary between RBM10 and UBA1 seems
similar to these insulators in terms of CTCF binding, there
are two notable distinct features. First, it does not appear
to be a typical LCR/ICR-type insulator, as little RNA
polymerase and acetylated H3 were associated around
the boundary. Second, the insulator function may not be
very strong, because the transcription from TSS1 was
repressed on Xi. The presence of two TSSs (i.e. tandem
promoter/enhancer elements) may also contribute to
maintain the UBA1 transcription activity by suppressing
heterochromatin spreading from the upstream inactive
region. In fact, chicken -globin insulator, containing
DNaseI-hypersensitive site 4, was not suﬃcient to inter-
cept the X-inactivation, when GFP reporter gene ﬂanked
with the insulator was introduced into X-linked Hprt locus
(65). Thus, CTCF-mediated insulators per se may not
be suﬃcient to maintain the transcription activity on Xi
due to the global silencing of the whole chromosome.
Alternatively, protein complexes assembled on strong
promoter/enhancer may also recruit CTCF to block the
heterochromatin spreading.
The correlation between CTCF binding and DNA
methylation has well been characterized in the insulators
of the imprinted genes (54,57) as well as in the enhancer
of Tsix (56). In the RBM10-UBA1 intergenic region,
the site-speciﬁc CpG hypomethylation was also detected
exclusively on Xi in the methylated domains on Xa. From
the ChIP data, CTCF binding does not appear to be
restricted to this hypomethylated region, but the binding
was rather spread throughout the intergenic region. It is
thus suggested that the CTCF-mediated insulator activity
of UBA1 boundaries may be regulated by the speciﬁc CpG
methylation, but the insulator machinery may progres-
sively spread from the DNA methylation-free cardinal
point to their vicinities. In good agreement with this
notion, among seven CTCF binding sites in human H19
diﬀerential methylation region (DMR), only the sixth site
is reported to act as a key regulator for switching between
IGF2 and H19 expression, whereas the other sites can be
hyper-methylated (66).
Consistent with previous reports (7,34), we here showed
that PCTK1 and USP11, located 3 and 6kb downstream
UBA1, respectively, were also escaped in CF cells. As
many escape genes are clustered (7), it is likely that the
escaping from the inactivation is regulated at chromatin
domain levels. Recent studies also suggest that the
chromatin insulator activity is correlated with the forma-
tion of long-distance chromatin loops by CTCF and
cohesin (67,68). During and after X inactivation, Jarid1c
gene remains located outside the Xist-RNA accumulated,
transcriptionally silent compartment (69), suggesting that
the inactivated and escape domains can be separated into
diﬀerent chromatin loops anchored through CTCF and
cohesin. If this is the case, the UBA1-PCTK1-USP11
escape domain may be extruded from the inactivated X
chromosome body. The 30 boundary of this escape domain
should be laid in the intergenic region between USP11
and ZNF157, which is located  122kb downstream, as
ZNF157 and further downstream genes are silenced
[Figure 1B and data not shown; (7)]. The large intergenic
sequence between USP11 and ZNF157, however, pre-
sented a great diﬃculty to exploring the 30 boundary of
UBA1 escape domain.
Repetitive sequences in human RBM10-UBA1
intergenic region
In human, more than 15% of the X-linked genes escape
the inactivation, and escape genes are spread throughout
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Figure 5. Schematic representation of RBM10-UBA1 region. The enrichment of histone modiﬁcations (H3K9Ac and H3K9me3), CpG methylation
status and CTCF binding sites are shown.
Nucleic Acids Research, 2009,Vol.37, No. 22 7425X chromosome with enrichments in PARs (7). Recent
bioinformatic analyses revealed that the primary DNA
sequence is correlated with the chromatin status on
human Xi; Alu repetitive elements and CAG/CGT and
GATA repeats are signiﬁcantly enriched in the escape
domain, whereas the long interspersed nuclear element
(LINE) and mammalian-wide interspersed repeat (MIR)
preferentially distributed in inactivated domains (70,71).
The UBA1 boundary region indeed contains an Alu
variant, in which the hypomethylated CpG sites were
mapped. As mouse Uba1 is not an escape gene (72), the
insertion of Alu element between RBM10 and UBA1 may
contribute to the establishment of the escape domain in
human. Although the downstream boundary region is not
identiﬁed, fragmented Alu repeat-containing sequences
account for  45% of the entire 122kb intergenic region
between USP11 and ZNF157, supporting the notion that
Alu sequence may disturb the heterochromatin spreading
on Xi. Further identiﬁcation of the boundaries between
the inactivated and escape domains may draw more
clariﬁed view how those domains are established and
maintained.
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